Brokerage wars are heating up the Indian retail scene in 2025: Zerodha vs Groww is a debate about cost, trust, and simplicity. Upstox rides in as a criticized underdog, while investors chase sharper stock-analysis tools.
Rivalry snapshot — Groww has captured a massive following with a simple, scroll-friendly interface and 12.6M active users, while Zerodha stays focused on a clean core and zero brokerage for delivery [1].
Pricing and features — Zerodha Coin offers 0 fee for mutual funds, and Groww is described in threads as charging similar FnO brokerage to Zerodha; some opinions say Groww doesn’t charge AMC, relying on brokerage instead [1].
Upstox under fire — a critical post accuses Upstox of being the most expensive broker, with Rs. 50+GST for nominee changes, Rs. 20 withdrawals, and a push toward the “Upstox Plus” plan that can raise costs. It also cites broken lifetime AMC promises and aggressive MTF pitches, plus concerns about company culture and investor optics [3].
Avg buy price after transfer — Traders transferring positions to Zerodha ask how to properly know their average buy price, with a note to update it in the Kite console [2].
Stock-analysis resources — readers show interest in stock-analysis sites, with mentions of a website that analyzes stocks from screener data and references to TradingView and screener.in [4].
Bottom line: in 2025, cost clarity, platform reliability, and accessible analysis tools are shaping where Indian retail investors park their money. Watch how Zerodha, Groww, and Upstox evolve on those fronts.
References
Zerodha walked so Groww could run.
Compares Zerodha and Groww, noting UI simplicity, marketing, MF platforms, zero brokerage, AMC charges, and user experiences in India today.
View sourceStocks transferred to zerodha. How to properly know avg buy price ?
Discusses determining average buy price after shares move to Zerodha, whether CDSL provides values, and tax implications of profits later.
View sourceSincere request to all investors and traders
User accuses Upstox of exploiting customers, high fees, dark patterns, questionable governance; calls for retail investors to stop trading there.
View sourceWant to know about the website
User seeks link to a stock-analysis website; claimed to judge buys from Screener data; mentions Chartink or TradingView as alternatives.
View source